# EDGAR Filing Document

**Accession Number:** 0000912463
**File Stem:** 0000912463-23-000018
**Filing Date:** 2023-3
**Character Count:** 18940
**Document Hash:** 5fd8fbe6c4655ddc801bf1b515508f4d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000912463-23-000018.hdr.sgml**: 20230331

**ACCESSION NUMBER**: 0000912463-23-000018

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 15

**CONFORMED PERIOD OF REPORT**: 20230331

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230331

**DATE AS OF CHANGE**: 20230331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GUESS INC
- **CENTRAL INDEX KEY:** 0000912463
- **STANDARD INDUSTRIAL CLASSIFICATION:** WOMEN'S, MISSES', CHILDREN'S & INFANTS' UNDERGARMENTS [2340]
- **IRS NUMBER:** 953679695
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0128

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-11893
- **FILM NUMBER:** 23788293

**BUSINESS ADDRESS:**
- **STREET 1:** ATTN:  JASON MILLER
- **STREET 2:** 1444 SOUTH ALAMEDA STREET
- **CITY:** LOS ANGELES
- **STATE:** CA
- **ZIP:** 90021
- **BUSINESS PHONE:** (213) 765-3100

**MAIL ADDRESS:**
- **STREET 1:** ATTN:  JASON MILLER
- **STREET 2:** 1444 SOUTH ALAMEDA STREET
- **CITY:** LOS ANGELES
- **STATE:** CA
- **ZIP:** 90021

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GUESS INC ET AL/CA/
- **DATE OF NAME CHANGE:** 19940902

?xml version="1.0" ? ges-20230331

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 8-K** 

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the**

**Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): March 31, 2023** 

**GUESS?, INC.**

(Exact name of registrant as specified in its charter)

**Delaware** 

(State or other jurisdiction of incorporation)

---

| | |
|:---|:---|
| **1-11893** | **95-3679695** |
| (Commission File Number) | (IRS Employer Identification No.) |

---

**Strada Regina 44, Bioggio, Switzerland CH-6934** 

(Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code: **+41 91 809 5000** 

**Not applicable**

(Former name or former address, if changed since last report)

---

| | |
|:---|:---|
| Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: | Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: |
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |

---

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, par value $0.01 per share | GES | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

---

| | |
|:---|:---|
| Emerging growth company | ☐ |
| If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □ | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □ |

---

------

**Item 5.02. Departure of Directors or Certain Principal Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**

*Amendment to Interim Chief Financial Officer's Employment Agreement*

Guess?, Inc. (the "Company") is a party to an Employment Agreement, dated March 14, 2022, with Dennis Secor, the Company's Interim Chief Financial Officer and Chief Accounting Officer (the "Employment Agreement"). On March 31, 2023, the Company and Mr. Secor entered into a letter agreement to amend the Employment Agreement (the "Amendment").

The Employment Agreement had provided for the term of Mr. Secor's employment with the Company to end on March 31, 2023. The Amendment extends the term of Mr. Secor's employment through March 31, 2024, subject to earlier termination as provided in the Employment Agreement and in the Amendment, at an initial base salary rate of $750,000. Mr. Secor will continue to serve as the Company's Interim Chief Financial Officer and Chief Accounting Officer until such time as determined by the Company's Board of Directors. Mr. Secor will not receive an annual bonus opportunity for fiscal year 2024 but he will be entitled to a retention bonus of $350,000 if he remains employed with the Company through March 31, 2024. On April 1, 2023, the Company will grant Mr. Secor an award of restricted stock units that has a grant date fair value of $500,000. The restricted stock units will be scheduled to vest, subject to Mr. Secor's continued employment with the Company, on March 31, 2024. If Mr. Secor is entitled to severance benefits in accordance with the terms of the Employment Agreement due to a termination of his employment by the Company without cause or by Mr. Secor for good reason (in either case prior to March 31, 2024), his severance benefits will include payment of the retention bonus and full vesting of the new restricted stock unit award. Mr. Secor will also be entitled to a pro-rated payment of his retention bonus and pro-rata vesting of the new restricted stock unit award if his employment with the Company ends prior to March 31, 2024 due to his death or disability.

The Amendment is attached hereto as Exhibit 10.1 and is incorporated herein by reference. The foregoing description of the Amendment is qualified in its entirety by reference to such exhibit.

**Item 9.01. Financial Statements and Exhibits.**

(d) Exhibits.

---

| | |
|:---|:---|
| **<u>Exhibit No.</u>** | **<u>Description</u>** |
| <u>[10.1](guess-secoragreement.htm)</u> | <u>[Amendment to Employment Agreement, dated March 31, 2023, between Guess?, Inc. and Dennis Secor](guess-secoragreement.htm)</u> |
| 104 | Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, Guess?, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
| Dated:  | March 31, 2023 | GUESS?, INC. | GUESS?, INC. |
|  |  | By: | /s/ Carlos Alberini |
|  |  |  | Carlos Alberini<br>*Chief Executive Officer* |

---

## Exhibit 10.1

![image_0.jpg](image_0.jpg)

GUESS?, INC.

March 31, 2023

Dennis Secor

**Re:&nbsp;&nbsp;&nbsp;&nbsp;*<u>Amendment of Employment Agreement</u>***

Dear Dennis:

Reference is made to the Employment Agreement between you and Guess?, Inc. (the "<u>Company</u>"), dated March 14, 2022 (the "<u>Employment Agreement</u>"). This letter agreement amends certain provisions of the Employment Agreement as set forth below, in each case effective as of March 31, 2023 except as otherwise provided below. Capitalized terms in this letter agreement that are not otherwise defined herein shall have the meanings ascribed to them in the Employment Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp;<u>Extension of Employment Term</u>. Section 2 of the Employment Agreement is hereby amended to provide that the Employment Term shall end on March 31, 2024 and your employment with the Company shall end on March 31, 2024 (unless you and the Company mutually agree in writing, by formal amendment to the Employment Agreement), in each case subject to earlier termination as provided in Section 7 of the Employment Agreement. During the portion of the Employment Term that you no longer serve as the Company's Chief Financial Officer, you will serve the Company in the position of Executive Vice President, Finance, still reporting to the Company's CEO.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;&nbsp;&nbsp;&nbsp;<u>Time Commitment</u>. Section 1 of the Employment Agreement is hereby amended to provide that, as to such portion of the Employment Term from and after September 1, 2023 (if any), it is expected that your work each week will generally not require a significant amount of time except for each week in which the Company releases its quarterly earnings and for each week prior thereto (in such two week periods you agree that you will be present in the Company's offices in Los Angeles and you will devote your full-time attention to your duties for the Company). However, there will be no reduction to your compensation from the levels set forth herein for any week that you do not devote all of your business time to your Company duties (and, similarly, there will be no increase to your compensation for any week where your duties for the Company require you to spend more than the time anticipated). For avoidance of doubt, you will remain classified as "exempt" from overtime throughout the Employment Term.

**EXECUTIVE OFFICES •** 1444 South Alameda Street, Los Angeles, CA 90021 **•** 213.765.3100

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;&nbsp;&nbsp;&nbsp;<u>Base Salary and Benefits</u>. Section 3 of the Employment Agreement is hereby amended to provide that, effective as of April 1, 2023 and as to the remaining portion of the Employment Term from and after that date, your annual rate of Base Salary shall be as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• for the portion of the Employment Term falling on or after April 1, 2023 and on or before August 31, 2023, your annual rate of Base Salary shall be Seven Hundred and Fifty Thousand U.S. Dollars ($750,000); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• for the portion of the Employment Term falling on or after September 1, 2023 and on or before March 31, 2024, your annual rate of Base Salary shall be Seventy-Five Thousand U.S. Dollars ($75,000).

For purposes of clarity, you will not be entitled to receive the Base Salary provided in this paragraph at any time after the Employment Term; provided, however, that if your employment with the Company terminates prior to March 31, 2024 and you are entitled to receive continued payment of your Base Salary through March 31, 2024 as severance as provided in Section 8(c)(iii) of the Employment Agreement (as amended hereby) in connection with such termination of your employment, the amount of such severance payments during the applicable period shall be determined in accordance with this paragraph.

Section 6 of the Employment Agreement is hereby amended to provide that you will cease accruing vacation time effective as of August 31, 2023. Your accrued and unused vacation time as of that date will be cashed out (based on your rate of Base Salary as in effect on that date) and paid on or promptly after that date.

During the Employment Term, you will continue to be eligible to participate in medical, dental, life, and disability benefits and perquisites on terms not less favorable to you than the terms of the applicable arrangement as applied to officers of the Company generally. Participation in any benefit plan remains subject to satisfying the applicable eligibility requirements. The Company reserves the right to amend or modify the terms and conditions of its benefits plans, and to terminate any benefit plan, from time to time.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;&nbsp;&nbsp;&nbsp;<u>Retention Bonus</u>. Section 4 of the Employment Agreement is hereby amended to clarify that you will not be eligible for an annual bonus for the Company's fiscal year 2024 and that, in lieu of such annual bonus opportunity and subject to your continued employment with the Company through March 31, 2024, you will be entitled to receive a bonus in the amount of $350,000 (the "Retention Bonus") (if earned, to be paid on or promptly after that date); provided, however, that if your employment with the Company terminates prior to March 31, 2024 and you are entitled to receive the severance payments provided in Section 8(c)(iii) of the Employment Agreement (as amended hereby) in connection with such termination of your employment, you will also be entitled to receive the full amount of the Retention Bonus (in such circumstances, to be paid on, or within

------

ten (10) business days following, the date that is sixty (60) days after your Severance Date).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;&nbsp;&nbsp;&nbsp;<u>New Restricted Stock Unit Award</u>. Section 5 of the Employment Agreement is hereby amended to provide that, on April 1, 2023, the Company will grant you a restricted stock unit award with a "Grant Date Value" of $500,000 (the "2023 Restricted Stock Unit Award") under the Equity Plan. The number of shares of the Company's common stock subject to the 2023 Restricted Stock Unit Award shall be determined by dividing the Grant Date Value set forth above by the closing price (in regular trading on the New York Stock Exchange) for a share of the Company's common stock on March 31, 2023 (or, if such date is not a trading day on the New York Stock Exchange, as of the most recent New York Stock Exchange trading day preceding such date), and rounding any fractional share up to the next whole share. The 2023 Restricted Stock Unit Award will be scheduled to vest as to 100% of the stock units subject to such award on March 31, 2024, subject to your continued employment by the Company through such date. The 2023 Restricted Stock Unit Award will be evidenced by a restricted stock unit award agreement using the Company's standard form for employee restricted stock unit award grants under the Equity Plan (the same form as was used for your restricted stock units awarded by the Company in fiscal year 2023), and will be subject to the terms and conditions of such restricted stock unit award agreement and the Equity Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.&nbsp;&nbsp;&nbsp;&nbsp;<u>Severance</u>. Sections 7 and 8 of the Employment Agreement are hereby amended, effective as of April 1, 2023, to change each reference to "March 31, 2023" in such sections to "March 31, 2024," and Section 8 of the Employment Agreement is hereby amended to provide that each reference to the "Restricted Stock Unit Award" in such section shall also refer to the 2023 Restricted Stock Unit Award. For clarity, if you are entitled to severance benefits pursuant to Section 8, you will not be entitled to any bonus with respect to fiscal year 2023 (as any bonus due to you with respect to fiscal year 2023 will have already been paid; and, for clarity, if your bonus under the Employment Agreement with respect to fiscal year 2023 has not been paid as of the date of this letter agreement, it will be paid promptly after the date of this letter agreement) or fiscal year 2024, but you will be entitled to the retention bonus provided for and in accordance with Section 4 above (or, in the event that benefits are triggered in connection with a termination of employment due to your death or Disability, in accordance with Section 7 below).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.&nbsp;&nbsp;&nbsp;&nbsp;<u>Death/Disability Benefits</u>. Section 8(a) of the Employment Agreement is hereby amended to provide that, if your employment with the Company terminates due to your death or Disability after March 31, 2023 and prior to March 31, 2024, (i) you will be entitled to payment of a pro-rated amount of your Retention Bonus, such amount to be determined by multiplying the Retention Bonus by the Pro-Rata Fraction (as defined below) and to be paid within 30 days following your Severance Date, and (ii) the 2023 Restricted Stock Unit Award, to the extent it is outstanding and otherwise unvested on the Severance Date, and notwithstanding anything contained in the applicable award agreement or the Equity Plan (or any

------

successor equity compensation plan) to the contrary, will vest as of the Severance Date as to a pro-rata portion of the total number of stock units subject to the award, such portion to be determined by multiplying the total number of stock units subject to the award by the Pro-Rata Fraction. For purposes of this paragraph, "Pro-Rata Fraction" means the fraction obtained by dividing (i) the total number of days you are employed by the Company from and including April 1, 2023 through and including the Severance Date, by (ii) the total number of days in the period from and including April 1, 2023 through and including March 31, 2024.

Except as expressly set forth herein, the Employment Agreement shall remain in full force and effect in accordance with its current terms. This letter agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

If this letter agreement accurately sets forth our understanding with respect to the foregoing matters, please indicate your acceptance by signing this letter and returning it to the undersigned. This letter agreement shall be a binding agreement between the Company and you. A duplicate copy of this letter agreement is included for your records with the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Guess?, Inc.

By: <u>/s/ Carlos Alberini&nbsp;&nbsp;&nbsp;&nbsp;</u>

Its: <u>Chief Executive Officer&nbsp;&nbsp;&nbsp;&nbsp;</u>

Accepted and Agreed:

<u>/s/ Dennis Secor&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

Dennis Secor

Date: March 31, 2023

<br>